Intranasal Calcitriol Accelerates Improvement of Sinonasal Inflammation and Olfactory Impairment in Mice After Cessation of Chronic Cigarette‐Smoke Exposure
International Forum of Allergy & Rhinology · 2025
DOI: 10.1002/alr.23504 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2025. Verfasst von Logan Langerude und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Calcitriol, Sinusitis, Rhinitis, Olfaction Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS, National Institutes of Health Awards, NIAID NIH HHS.
Abstract (Originalsprache)
Rationale
Smoking has been shown to be associated with circulating deficiencies in 25(OH)D3 and reduced sinonasal tissue levels of the active form of vitamin D, 1,25(OH)2D3. Given vitamin D's ability to reduce inflammation, we sought to examine if intranasal (IN) delivery of calcitriol [clinical analog of 1,25(OH)2D3] could reduce inflammation and improve disease severity in a murine model of chronic cigarette smoke‐induced sinonasal inflammation (CS‐SI).
Methods
Mice were exposed to CS 5 h/day, 5 days/week for 9 months, and then began IN calcitriol three times per week for 4 weeks. Micro‐CT was used to assess disease severity. Sinonasal tissues were collected for RNA‐seq analysis. Olfactory function was assessed using a T‐maze odorant avoidance sniff behavior test. Nasal lavage fluid (NALF) was used for cytology and cytokines analysis.
Results
Quantification of disease severity by micro‐CT showed IN calcitriol reduced opacification by 18%, as compared to smoke cessation alone, in which only a 5% reduction was noted. H&E analysis of NAFL demonstrated heightened neutrophil infiltration and neutrophil‐associated chemokines in CS‐SI mice, which was reduced with IN calcitriol treatment. RNA‐seq pathway analysis demonstrated that smoking was associated with odorant binding changes and that calcitriol treatment reduced neutrophil migration and inflammation. Lastly, IN calcitriol reversed olfactory loss caused in CS‐SI.
Conclusions
IN delivery of calcitriol accelerates inflammatory resolution in the nose and olfactory mucosa after prolonged CS exposure. Furthermore, treatment was associated with improved olfactory function in mice CS‐SI, as such local delivery of calcitriol may serve as a novel treatment for modulating sinonasal inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Division of Division of Rhinology & Skull Base Surgery Department of Otolaryngology, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Jennifer K Mulligan
Förderung
- NIDCD NIH HHS
- National Institutes of Health Awards
- NIAID NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Langerude, L., McQuiston, A., Atkinson, C., & Mulligan, J. K. (2025). Intranasal Calcitriol Accelerates Improvement of Sinonasal Inflammation and Olfactory Impairment in Mice After Cessation of Chronic Cigarette‐Smoke Exposure. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23504
Vancouver
Langerude L, McQuiston A, Atkinson C, Mulligan JK. Intranasal Calcitriol Accelerates Improvement of Sinonasal Inflammation and Olfactory Impairment in Mice After Cessation of Chronic Cigarette‐Smoke Exposure. International Forum of Allergy & Rhinology. 2025. doi:10.1002/alr.23504
BibTeX
@article{Langerude2025,
author = {Langerude, Logan and McQuiston, Alex and Atkinson, Carl and Mulligan, Jennifer K},
title = {Intranasal Calcitriol Accelerates Improvement of Sinonasal Inflammation and Olfactory Impairment in Mice After Cessation of Chronic Cigarette‐Smoke Exposure},
journal = {International Forum of Allergy & Rhinology},
year = {2025},
doi = {10.1002/alr.23504}
}
EUVIMED